Located in Lebanon, NH, The Doorway at Dartmouth-Hitchcock offers
outpatient care for people seeking help with substance use and related challenges.
Care here features levels of care including outpatient and typical program lengths around 5 days.
The clinical model combines evidence-based and supportive therapies such as 1-on-1 counseling,
family therapy and
medication-assisted treatment and a treatment philosophy that is evidence-based and medical.
This center serves men and women and treats drug addiction, opioids, prescription drugs, benzodiazepines, cocaine and ecstasy.
The Doorway at Dartmouth-Hitchcock accepts 24 insurance options, including ITU Funds, Intermountain Healthcare, Kaiser Permanente and MHN, and can help verify your specific benefits.
Ongoing support continues after treatment through outpatient treatment, discharge planning, relapse prevention planning and naloxone and overdose education.
For details on admissions, availability, and coverage, reach out to The Doorway at Dartmouth-Hitchcock or call our 24/7 helpline.
Evidence-Based Context: According to SAMHSA's National Survey on Drug Use and Health (2023), approximately 48.7 million Americans aged 12 or older had a substance use disorder in the past year. The National Institute on Drug Abuse (NIDA) emphasizes that treatment programs combining behavioral therapy with medication-assisted approaches show the highest rates of sustained recovery. Facilities like The Doorway at Dartmouth-Hitchcock provide structured pathways to evidence-based care.
Sources: SAMHSA NSDUH 2023, NIDA Principles of Drug Addiction Treatment (4th Ed.)